Marker Therapeutics, Inc. (MRKR) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $3.55M | -46.2% |
| 2024 | $6.59M | +99.1% |
| 2023 | $3.31M | -5.8% |
| 2022 | $3.51M | +183.0% |
| 2021 | $1.24M | +166.0% |
| 2020 | $466.8K | +118.9% |
| 2019 | $213.2K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $3.55M | -46.2% |
| 2024 | $6.59M | +99.1% |
| 2023 | $3.31M | -5.8% |
| 2022 | $3.51M | +183.0% |
| 2021 | $1.24M | +166.0% |
| 2020 | $466.8K | +118.9% |
| 2019 | $213.2K | — |